Population-Based Study on Cancer Subtypes, Guideline-Concordant Adjuvant Therapy, and Survival Among Women With Stage I-III Breast Cancer.

MLA

Hsieh, Mei-Chin, et al. “Population-Based Study on Cancer Subtypes, Guideline-Concordant Adjuvant Therapy, and Survival Among Women With Stage I-III Breast Cancer.” Journal of the National Comprehensive Cancer Network : JNCCN, vol. 17, no. 6, June 2019, pp. 676–86. EBSCOhost, https://doi.org/10.6004/jnccn.2018.7272.

APA

Hsieh, M.-C., Zhang, L., Wu, X.-C., Davidson, M. B., Loch, M., & Chen, V. W. (2019). Population-Based Study on Cancer Subtypes, Guideline-Concordant Adjuvant Therapy, and Survival Among Women With Stage I-III Breast Cancer. Journal of the National Comprehensive Cancer Network : JNCCN, 17(6), 676–686. https://doi.org/10.6004/jnccn.2018.7272

Chicago

Hsieh, Mei-Chin, Lu Zhang, Xiao-Cheng Wu, Mary B Davidson, Michelle Loch, and Vivien W Chen. 2019. “Population-Based Study on Cancer Subtypes, Guideline-Concordant Adjuvant Therapy, and Survival Among Women With Stage I-III Breast Cancer.” Journal of the National Comprehensive Cancer Network : JNCCN 17 (6): 676–86. doi:10.6004/jnccn.2018.7272.